Trial Profile
Rituximab for the Treatment of Inhibitors in Congenital Hemophilia A (A TMH CTN Study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jul 2023
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Haemophilia A
- Focus Proof of concept; Therapeutic Use
- Acronyms RICH
- 09 Nov 2015 New trial record